PDUFA V Patient-Focused Drug Development

 
Docket ID: FDA-2012-N-0967
Agency: Food and Drug Administration (FDA)
Parent Agency: Department of Health and Human Services (HHS)
Docket Details open glossary dialog  
Related RINs: None
Related Dockets: FDA-2014-N-1413
Short Title: PDUFA V Patient-Focused Drug Development
Keyword(s): cder2012158, PDUFA V, Request for Comments, Public Meeting, open, Patient-Focused Drug Development, for Huntington’s and Parkinson’s Diseases, 2015-462, CDER, 2015-520, Nontuberculous Mycobacterial Lung Infections
Type: Nonrulemaking
Docket Status: OPEN
Center: CDER
Docket Item Code: N
 

Primary Documents

View All  (8)
Comment Period Closed
Dec 15, 2015 11:59 PM ET
Notice
Posted: 08/03/2015
ID: FDA-2012-N-0967-0748
Comment Period Closed
Nov 23, 2015 11:59 PM ET
Notice
Posted: 07/17/2015
ID: FDA-2012-N-0967-0747
Comment Period Closed
Dec 05, 2014 11:59 PM ET
Notice
Posted: 10/08/2014
ID: FDA-2012-N-0967-0595
Comment Period Closed
Jul 14, 2014 11:59 PM ET
Notice
Posted: 02/07/2014
ID: FDA-2012-N-0967-0592
Comment Period Closed
Nov 01, 2012 11:59 PM ET
Notice
Posted: 09/24/2012
ID: FDA-2012-N-0967-0001

Supporting Documents

 
No documents available.

Comments

View All  (853)

5,457
Comments Received*
*This count refers to the total comment/submissions received on this docket, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.